XTANT MEDICAL HOLDINGS, INC. Revenue
XTANT MEDICAL HOLDINGS, INC. (XTNT) reported Revenue of $23.03 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-11
- XTANT MEDICAL HOLDINGS, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $23.03M, a 34.96% decline year-over-year.
- XTANT MEDICAL HOLDINGS, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $20.88M, a 36.53% decline year-over-year.
- XTANT MEDICAL HOLDINGS, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $32.36M, a 2.68% increase year-over-year.
- XTANT MEDICAL HOLDINGS, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $33.26M, a 19.04% increase year-over-year.
- XTANT MEDICAL HOLDINGS, INC. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $133.93M, a 14.21% increase from fiscal 2024.
- XTANT MEDICAL HOLDINGS, INC. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $117.27M, a 28.44% increase from fiscal 2023.
- XTANT MEDICAL HOLDINGS, INC. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $91.30M, a 57.50% increase from fiscal 2022.
- XTANT MEDICAL HOLDINGS, INC. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $57.97M, a 4.90% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $23.03M 10-Q · filed 2026-08-11 | $43.91M 10-Q · filed 2026-08-11 | $76.27M derived: sum of 3 quarters · filed 2026-08-11 | $109.53M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $20.88M 10-Q · filed 2026-05-13 | $53.24M derived: sum of 2 quarters · filed 2026-05-13 | $86.50M derived: sum of 3 quarters · filed 2026-05-13 | $121.91M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $32.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $65.61M derived: sum of 2 quarters · filed 2026-03-31 | $101.02M derived: sum of 3 quarters · filed 2026-08-11 | $133.93M 10-K · filed 2026-03-31 |
| 2025-09-30 | $33.26M 10-Q · filed 2025-11-10 | $68.67M derived: sum of 2 quarters · filed 2026-08-11 | $101.57M 10-Q · filed 2025-11-10 | $133.08M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $35.41M 10-Q · filed 2026-08-11 | $68.31M 10-Q · filed 2026-08-11 | $99.83M derived: sum of 3 quarters · filed 2026-08-11 | $127.77M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $32.90M 10-Q · filed 2026-05-13 | $64.42M derived: sum of 2 quarters · filed 2026-05-13 | $92.35M derived: sum of 3 quarters · filed 2026-05-13 | $122.30M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $31.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $59.45M derived: sum of 2 quarters · filed 2026-03-31 | $89.39M derived: sum of 3 quarters · filed 2026-03-31 | $117.27M 10-K · filed 2026-03-31 |
| 2024-09-30 | $27.94M 10-Q · filed 2025-11-10 | $57.88M derived: sum of 2 quarters · filed 2025-11-10 | $85.75M 10-Q · filed 2025-11-10 | $113.86M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $29.94M 10-Q · filed 2025-08-12 | $57.82M 10-Q · filed 2025-08-12 | $85.92M derived: sum of 3 quarters · filed 2025-08-12 | $110.94M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $27.87M 10-Q · filed 2025-05-12 | $55.98M derived: sum of 2 quarters · filed 2025-05-12 | $81.00M derived: sum of 3 quarters · filed 2025-05-12 | $101.23M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $28.11M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $53.13M derived: sum of 2 quarters · filed 2025-03-06 | $73.36M derived: sum of 3 quarters · filed 2025-03-06 | $91.30M 10-K · filed 2025-03-06 |
| 2023-09-30 | $25.02M 10-Q · filed 2024-11-12 | $45.25M derived: sum of 2 quarters · filed 2024-11-12 | $63.20M 10-Q · filed 2024-11-12 | $78.46M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $20.23M 10-Q · filed 2024-08-08 | $38.18M 10-Q · filed 2024-08-08 | $53.45M derived: sum of 3 quarters · filed 2024-08-08 | $67.91M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $17.94M 10-Q · filed 2024-05-15 | $33.21M derived: sum of 2 quarters · filed 2024-05-15 | $47.67M derived: sum of 3 quarters · filed 2024-05-15 | $62.95M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $15.27M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $29.73M derived: sum of 2 quarters · filed 2024-04-01 | $45.01M derived: sum of 3 quarters · filed 2024-04-01 | $57.97M 10-K · filed 2024-04-01 |
| 2022-09-30 | $14.46M 10-Q · filed 2023-11-14 | $29.74M derived: sum of 2 quarters · filed 2023-11-14 | $42.70M 10-Q · filed 2023-11-14 | $56.67M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $15.28M 10-Q · filed 2023-08-01 | $28.24M 10-Q · filed 2023-08-01 | $42.21M derived: sum of 3 quarters · filed 2023-08-01 | $55.98M derived: sum of 4 quarters · filed 2023-08-01 |
| 2022-03-31 | $12.96M 10-Q · filed 2023-05-04 | $26.93M derived: sum of 2 quarters · filed 2023-05-04 | $40.71M derived: sum of 3 quarters · filed 2023-05-04 | $55.68M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $13.97M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $27.75M derived: sum of 2 quarters · filed 2023-03-07 | $42.72M derived: sum of 3 quarters · filed 2023-03-07 | $55.26M 10-K · filed 2023-03-07 |
| 2021-09-30 | $13.78M 10-Q · filed 2022-11-03 | $28.75M derived: sum of 2 quarters · filed 2022-11-03 | $41.29M 10-Q · filed 2022-11-03 | $55.31M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $14.97M 10-Q · filed 2022-08-04 | $27.52M 10-Q · filed 2022-08-04 | $41.53M derived: sum of 3 quarters · filed 2022-08-04 | $55.55M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $12.54M 10-Q · filed 2022-05-05 | $26.56M derived: sum of 2 quarters · filed 2022-05-05 | $40.57M derived: sum of 3 quarters · filed 2022-05-05 | $51.10M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $14.02M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $28.03M derived: sum of 2 quarters · filed 2022-03-08 | $38.56M derived: sum of 3 quarters · filed 2022-03-08 | $53.34M 10-K · filed 2022-03-08 |
| 2020-09-30 | $14.02M 10-Q · filed 2021-11-12 | $24.55M derived: sum of 2 quarters · filed 2021-11-12 | $39.32M 10-Q · filed 2021-11-12 | $56.29M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $10.53M 10-Q · filed 2021-08-05 | $25.31M 10-Q · filed 2021-08-05 | $42.27M derived: sum of 3 quarters · filed 2021-08-05 | $57.99M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $14.78M 10-Q · filed 2021-05-11 | $31.74M derived: sum of 2 quarters · filed 2021-05-11 | $47.46M derived: sum of 3 quarters · filed 2021-05-11 | $62.73M derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | $16.96M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $32.69M derived: sum of 2 quarters · filed 2021-02-24 | $47.96M derived: sum of 3 quarters · filed 2021-02-24 | $64.68M 10-K · filed 2021-02-24 |
| 2019-09-30 | $15.72M 10-Q · filed 2020-10-29 | $30.99M derived: sum of 2 quarters · filed 2020-10-29 | $47.72M 10-Q · filed 2020-10-29 | $65.98M derived: sum of 4 quarters · filed 2020-10-29 |
| 2019-06-30 | $15.27M 10-Q · filed 2020-08-03 | $32.00M 10-Q · filed 2020-08-03 | $50.26M derived: sum of 3 quarters · filed 2020-08-03 | $67.53M derived: sum of 4 quarters · filed 2020-08-03 |
| 2019-03-31 | $16.73M 10-Q · filed 2020-05-07 | $34.99M derived: sum of 2 quarters · filed 2020-05-07 | $52.25M derived: sum of 3 quarters · filed 2020-05-07 | $71.00M derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $18.26M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $35.53M derived: sum of 2 quarters · filed 2020-03-05 | $54.27M derived: sum of 3 quarters · filed 2020-03-05 | $72.20M 10-K · filed 2020-03-05 |
| 2018-09-30 | $17.27M 10-Q · filed 2019-11-07 | $36.01M derived: sum of 2 quarters · filed 2019-11-07 | $53.94M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $18.74M 10-Q · filed 2019-08-08 | $36.67M 10-Q · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |